Reblozyl Phase 2 Success Shapes Bristol Myers Squibb Valuation Story [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Bristol-Myers Squibb (NYSE:BMY) reported positive top-line Phase 2 results for Reblozyl in Alpha-Thalassemia related anemia. The study included both non transfusion dependent and transfusion dependent Alpha-Thalassemia patients. Primary and key secondary endpoints were met, with improvements in hemoglobin levels and reduced transfusion burden. Safety findings were consistent with previously reported data for Reblozyl. Bristol-Myers Squibb is a large biopharmaceutical company focused on therapies in hematology, oncology and immunology, and Reblozyl is already an important asset in its blood disorder portfolio. Positive data in Alpha-Thalassemia extends the drug's potential reach into a rare disease area where treatment options are limited. For investors, it adds another data point on how BMY is using existing products to pursue additional indications instea
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- 2 Top Healthcare Dividend Stocks to Buy and Hold Forever [Yahoo! Finance]Yahoo! Finance
- Q4 Earnings Outperformers: Bristol-Myers Squibb (NYSE:BMY) And The Rest Of The Branded Pharmaceuticals Stocks [Yahoo! Finance]Yahoo! Finance
- ????????????????????????????????2035????158?2000??????????????(CAGR)3.8%??????????? [CNET News]CNET News
- 3 Top Dividend Stocks to Maximize Your Retirement Income [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb Adds Reblozyl Data And AI To Pipeline Story [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 3/3/26 - Form 4
- 2/11/26 - Form 10-K
- 2/5/26 - Form 8-K
- BMY's page on the SEC website